Filing Details
- Accession Number:
- 0001367644-21-000101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-27 16:37:50
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-27 16:37:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1685720 | C Kathryn Zoon | 400 Professional Drive Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-25 | 3,139 | $56.48 | 14,377 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86.
Billionaire Hedge Funds
